Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H. Móciková
Da-Epoch-R Versus R-Chop in High Risk DLBCL Patients: Analysis of the Czech Lymphoma Study Group (Clsg)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Predictive Value of Prima-Prognostic Index (Prima-Pi) in First Relapse of Follicular Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
What Is the Standard of Care for Primary Mediastinal B-Cell Lymphoma; R-Chop or DA-EPOCH-R?
British Journal of Haematology
Hematology
Polarix: A Phase 3 Study of Polatuzumab Vedotin (Pola) Plus R-CHP Versus R-Chop in Patients (Pts) With Untreated DLBCL
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
What Is the Standard of Care for Primary Mediastinal B Cell Lymphoma; R-Chop or DA-EPOCH-R? - Response to Melani Et Al
British Journal of Haematology
Hematology
Phase Ii Study of Durvalumab (Anti-Pd-L1) Combined With Either R-Chop or Lenalidomide and R-Chop in Previously Untreated, High-Risk Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
First‐line R‐CVP Versus R‐CHOP Induction Immunochemotherapy for Indolent Lymphoma With Rituximab Maintenance. A Multicentre, Phase III Randomized Study by the Polish Lymphoma Research Group PLRG4
British Journal of Haematology
Hematology
Predictive Value of Interim PET/CT in DLBCL Treated With R-Chop: Meta-Analysis
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Blood Lymphocyte-To-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated With R-Chop
PLoS ONE
Multidisciplinary
Treatment of High Risk Aggressive B Cell Lymphomas With Da Epoch R- The Austrian Experience
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Ofatumumab With Ivac for DLBCL Patients Who Failed R-Chop and Were Not Candidates for High-Dose Therapy and Asct - Phase 2 Trial of the Polish Lymphoma Research Group (Plrg-8)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology